Progress in healthcare does not come from a single breakthrough. It comes from many teams doing careful, disciplined work together. The E-Leviate clinical programme is supported
Phenomics Australia Strategic Partnerships Advisor Dr John Parisot, Therapeutic Innovation Australia (TIA)’s Dr Heather Donaghy, Director of Strategic Development, Cell & Gene Therapies and Small Molecule
Applications close on Friday the 17th of April 2026, 5pm (AEST) 👉 Learn more here: https://phenomicsaustralia.org.au/voucher-scheme/ In this Pipeline Accelerator round, Phenomics Australia is partnering with
Phenomics Australia (formerly the Australian Phenomics Network, APN) offers consolidated infrastructure and expertise supporting genomic medicine and biomedical research from discovery through into early clinical development and evaluation.
Phenomics Australia is a founding capability enabled by the National Collaborative Research Infrastructure Strategy (NCRIS). We would love to hear from you!
Please feel free to provide any ideas or general comments you might have so that we can further improve how Phenomics Australia can support you.
Have you recently had a publication accepted? Do you want to tell us about a grant you have received? Or maybe you have just been recently in the news? You can complete this form to tell us about your latest research developments.
Information provided will be used to inform press releases, website stories, social media content and more. This form is being used to capture everything that is happening at Phenomics Australia, which can then be used as part of our outreach and communications.
Once you have completed the form, the Communications and Outreach Coordinator will then be in contact with you.
Thanks.
_Get in touch to discuss how we can help with your research.
